ProQR Therapeutics (PRQR) Exchange Rate Effect (2014 - 2026)
ProQR Therapeutics (PRQR) posted quarterly Exchange Rate Effect of $327730.8 for Q1 2026, up 161.02% year-on-year from $125559.2 in Q1 2025, and up 2300.0% on a QoQ basis from $13655.5 in Q4 2025.
ProQR Therapeutics (PRQR) Exchange Rate Effect (2014 - 2026) Analysis & Trends
ProQR Therapeutics (PRQR) has reported Exchange Rate Effect for 13 consecutive years, with $327730.8 the latest figure, recorded in Q1 2026.
- Quarterly Exchange Rate Effect rose 161.02% year-over-year to $327730.8 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$669117.1 (down 552.31% YoY) and the FY2025 annual result came in at -$1.5 million, down 300.3% from the prior year.
- Exchange Rate Effect advanced to $327730.8 in Q1 2026 per PRQR's latest filing, from $13655.5 in the prior quarter.
- Over the last five years, Exchange Rate Effect for PRQR reached as high as $4.8 million in Q2 2022 and fell as low as -$1.8 million in Q4 2022.
- A 5-year average of $506255.8 and a median of $70553.2 in 2024 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect surged 434.74% — and 2025, when it plunged 1477.42%.
- Year by year, Exchange Rate Effect stood at -$1.8 million in 2022, then jumped by 86.74% to -$242384.3 in 2023, then jumped by 434.74% to $811361.4 in 2024, then sank by 98.32% to $13655.5 in 2025, then surged by 2300.0% to $327730.8 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $327730.8, $13655.5, and -$38690.4 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ProQR Therapeutics | 219.53 Mn | 175.72 Mn | - | 327,730.83 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 327,730.83 |
| Mar 31, 2026 | 327,730.83 |
| Dec 31, 2025 | 13,655.45 |
| Dec 31, 2025 | 13,655.45 |
| Sep 30, 2025 | -38,690.45 |
| Sep 30, 2025 | -38,690.45 |
| Jun 30, 2025 | -971,812.95 |
| Jun 30, 2025 | -971,812.95 |
| Mar 31, 2025 | -537,114.42 |
| Mar 31, 2025 | -537,114.42 |
| Dec 31, 2024 | 811,361.40 |
| Dec 31, 2024 | 811,361.40 |
| Sep 30, 2024 | -196,866.09 |
| Sep 30, 2024 | -196,866.09 |
| Jun 30, 2024 | 70,553.16 |
| Jun 30, 2024 | 70,553.16 |
| Mar 31, 2024 | 80,794.75 |
| Mar 31, 2024 | 80,794.75 |
| Dec 31, 2023 | -242,384.26 |
| Dec 31, 2023 | -242,384.26 |